{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T04:19:42Z","timestamp":1771474782205,"version":"3.50.1"},"reference-count":59,"publisher":"Oxford University Press (OUP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Crohn's and Colitis"],"published-print":{"date-parts":[[2007,9]]},"DOI":"10.1016\/j.crohns.2007.07.001","type":"journal-article","created":{"date-parts":[[2007,9,6]],"date-time":"2007-09-06T20:41:48Z","timestamp":1189111308000},"page":"2-9","source":"Crossref","is-referenced-by-count":11,"title":["Infliximab in paediatric inflammatory bowel disease"],"prefix":"10.1093","volume":"1","author":[{"given":"Pere","family":"Vilar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier Mart\u00edn","family":"de Carpi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia E.","family":"Acu\u00f1a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ma Luisa","family":"Masiques","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","reference":[{"key":"10.1016\/j.crohns.2007.07.001_bib1","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1097\/01.mco.0000222117.76536.49","article-title":"Enteral feeding in inflammatory bowel disease","volume":"9","author":"Griffiths","year":"2006","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10.1016\/j.crohns.2007.07.001_bib2","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1046\/j.1365-2036.2000.00707.x","article-title":"Mucosal healing and a fall in mucosal pro-inflammatory cytokine mRNA induced by a specific oral polymeric diet in paediatric Crohn's disease","volume":"14","author":"Fell","year":"2000","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.crohns.2007.07.001_bib3","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1097\/00054725-200407000-00024","article-title":"Mucosal healing in pediatric Crohn's disease: the goal of medical treatment","volume":"10","author":"D'Haens","year":"2004","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.crohns.2007.07.001_bib4","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.dld.2005.10.005","article-title":"Short- and long-term therapeutic efficacy of nutritional therapy and corticosteroids in paediatric Crohn's disease","volume":"38","author":"Berni-Canani","year":"2006","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.crohns.2007.07.001_bib5","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1046\/j.1365-2036.2003.01672.x","article-title":"Response to infliximab is related to disease duration in paediatric Crohn's disease","volume":"18","author":"Lionetti","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.crohns.2007.07.001_bib6","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.1111\/j.1572-0241.2000.03263.x","article-title":"Prolonged duration of response to infliximab in early but not late pediatric Crohn's disease","volume":"95","author":"Kugathasan","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.crohns.2007.07.001_bib7","doi-asserted-by":"crossref","first-page":"PG2Y16","DOI":"10.1097\/00005176-200505000-00103","article-title":"Infliximab as a first-line therapy in newly diagnosed Crohn's disease (CD) promotes longterm sustained remission and alters the course of the disease","volume":"40","author":"Bascietto","year":"2005","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.crohns.2007.07.001_bib8","first-page":"A577","article-title":"A randomized controlled trial evaluating the ideal medical management for Crohn's disease (CD): top-down vs step-up strategies","volume":"128","author":"Hommes","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.crohns.2007.07.001_bib9","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2036.2006.03134.x","article-title":"Review article: Altering the natural history of Crohn's disease. Evidence for and against current therapies","volume":"25","author":"Vermeire","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.crohns.2007.07.001_bib10","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/S0016-5085(99)70005-3","article-title":"Endoscopic and histological healing with infliximab anti-tumour necrosis factor antibodies in Crohn's disease: a European multicenter trial","volume":"116","author":"D'Haens","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.crohns.2007.07.001_bib11","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0140-6736(93)91375-V","article-title":"Tumour-necrosis-factor antibody treatment in Crohn's disease","volume":"342","author":"Derkx","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.crohns.2007.07.001_bib12","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1097\/00005176-199105000-00005","article-title":"Development and validation of a pediatric Crohn's disease activity index","volume":"12","author":"Hyams","year":"1991","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.crohns.2007.07.001_bib13","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1097\/00005176-199202000-00017","article-title":"Relationship of common laboratory parameters to the activity of Crohn's disease in children","volume":"14","author":"Hyams","year":"1992","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.crohns.2007.07.001_bib14","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/00005176-200407000-00010","article-title":"Infliximab therapy in 30 patients with refractory pediatric Crohn disease with and without fistulas in The Netherlands","volume":"39","author":"de Ridder","year":"2004","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.crohns.2007.07.001_bib15","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1053\/j.gastro.2006.12.003","article-title":"Induction and maintenance infliximab therapy for the treatment of moderate-to-severe Crohn's disease in children","volume":"132","author":"Hyams","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.crohns.2007.07.001_bib16","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/S0140-6736(02)08512-4","article-title":"Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial","volume":"359","author":"Hanauer","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.crohns.2007.07.001_bib17","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/00005176-200407000-00004","article-title":"Infliximab: how to use it in pediatric Crohn's disease","volume":"39","author":"Ruemmele","year":"2004","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.crohns.2007.07.001_bib18","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/01.MIB.0000160803.44449.a5","article-title":"Infliximab efficacy in pediatric ulcerative colitis","volume":"11","author":"Eidelwein","year":"2005","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.crohns.2007.07.001_bib19","first-page":"A615","article-title":"Infliximab outcome in children and adults with ulcerative colitis","volume":"120","author":"Kugathasan","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.crohns.2007.07.001_bib20","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/00005176-200203000-00017","article-title":"Infliximab as a novel therapy for pediatric ulcerative colitis","volume":"34","author":"Mamula","year":"2002","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.crohns.2007.07.001_bib21","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1097\/00005176-200403000-00013","article-title":"Infliximab in pediatric ulcerative colitis: two-year follow-up","volume":"38","author":"Mamula","year":"2004","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"Suppl. 1","key":"10.1016\/j.crohns.2007.07.001_bib22","doi-asserted-by":"crossref","first-page":"S282","DOI":"10.1097\/00005176-200406001-00717","article-title":"Infliximab for ulcerative colitis in children","volume":"39","author":"McGinnis","year":"2004","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.crohns.2007.07.001_bib23","first-page":"A616","article-title":"Infliximab therapy for pediatric ulcerative colitis","volume":"122","author":"Oliva-Hemker","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.crohns.2007.07.001_bib24","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/00005176-200408000-00008","article-title":"Infliximab is effective in acute but not chronic childhood ulcerative colitis","volume":"39","author":"Russell","year":"2004","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.crohns.2007.07.001_bib25","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1097\/MPG.0b013e31802e98d4","article-title":"Short- and long-term response to and weaning from infliximab therapy in pediatric ulcerative colitis","volume":"44","author":"Fanjiang","year":"2007","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.crohns.2007.07.001_bib26","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1345\/aph.10395","article-title":"Use of infliximab in pediatric patients with inflammatory bowel disease","volume":"35","author":"Serrano","year":"2001","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.crohns.2007.07.001_bib27","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1056\/NEJMoa050516","article-title":"Infliximab for induction and maintenance therapy for ulcerative colitis","volume":"353","author":"Rutgeerts","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.crohns.2007.07.001_bib28","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1365-2036.2006.03131.x","article-title":"Systematic review: infliximab therapy in ulcerative colitis","volume":"25","author":"Gisbert","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.crohns.2007.07.001_bib29","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/ibd.20054","article-title":"Predictors of early response to infliximab in patients with ulcerative colitis","volume":"13","author":"Ferrante","year":"2007","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.crohns.2007.07.001_bib30","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1111\/j.1572-0241.2002.06026.x","article-title":"Efficacy of anti-tumour necrosis factor therapy in patients with ulcerative colitis","volume":"97","author":"Su","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.crohns.2007.07.001_bib31","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1046\/j.1365-2036.2003.01411.x","article-title":"Infusion reactions to infliximab in children and adolescents: frequency, outcome and a predictive model","volume":"17","author":"Crandall","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.crohns.2007.07.001_bib32","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1111\/j.1572-0241.2003.07457.x","article-title":"The incidence and management of infusion reactions to infliximab: a large center experience","volume":"98","author":"Cheifetz","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.crohns.2007.07.001_bib33","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1097\/01.MIB.0000158166.88238.ea","article-title":"Premedication and infusion reactions with infliximab: results from a pediatric inflammatory bowel disease consortium","volume":"11","author":"Jacobstein","year":"2005","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.crohns.2007.07.001_bib34","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/MPG.0b013e31802f6424","article-title":"Hepatosplenic T cell lymphoma associated with infliximab use in young patients treated for inflammatory bowel disease","volume":"44","author":"Mackey","year":"2007","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.crohns.2007.07.001_bib35","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/00005176-200502000-00026","article-title":"Hepatosplenic T-cell lymphoma in an adolescent patient after immunomodulator and biologic therapy for Crohn's disease","volume":"40","author":"Thayu","year":"2005","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.crohns.2007.07.001_bib36","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1080\/1042819021000035662","article-title":"Hepatosplenic T-gammadelta lymphoma in a patient with Crohn's disease treated with azathioprine","volume":"44","author":"Navarro","year":"2003","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.crohns.2007.07.001_bib37","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/j.1600-0609.2006.00646.x","article-title":"A case of hepatosplenic gamma-delta T-cell lymphoma with a transient response to fludarabine and alemtuzumab","volume":"76","author":"Mittal","year":"2006","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.crohns.2007.07.001_bib38","first-page":"A26","article-title":"The clinical outcome of maintenance therapy with infliximab for luminal Crohn's disease is not affected by concomitant immunosuppressives: results of a multicenter randomized infliximab maintenance\/immunosuppressives discontinuation (IMID) trial","volume":"128","author":"Van Assche","year":"2005","journal-title":"Gastroenterology"},{"issue":"23","key":"10.1016\/j.crohns.2007.07.001_bib39","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1365-2036.2006.02786.x","article-title":"Review article: infliximab therapy for inflammatory bowel disease \u2014 seven years on","volume":"15","author":"Rutgeerts","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.crohns.2007.07.001_bib40","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1097\/00054725-200608000-00021","article-title":"Cardiac involvement in children with IBD during infliximab therapy","volume":"12","author":"Barbato","year":"2006","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.crohns.2007.07.001_bib41","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/j.1651-2227.2007.00042.x","article-title":"Severe adverse reactions to infliximab therapy are common in young children with inflammatory bowel disease","volume":"96","author":"Kolho","year":"2007","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.crohns.2007.07.001_bib42","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/S0889-8553(03)00046-3","article-title":"Inflammatory bowel disease in early childhood and adolescence: special considerations","volume":"32","author":"Mamula","year":"2003","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1016\/j.crohns.2007.07.001_bib43","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.admecli.2003.11.012","article-title":"Inflammatory bowel disease","volume":"15","author":"Fish","year":"2004","journal-title":"Adolesc Med Clin"},{"key":"10.1016\/j.crohns.2007.07.001_bib44","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/00005176-199305000-00005","article-title":"Growth failure in pediatric inflammatory bowel disease","volume":"16","author":"Markowitz","year":"1993","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.crohns.2007.07.001_bib45","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/S0016-5085(88)80072-6","article-title":"Decreased height velocity in children and adolescents before the diagnosis of Crohn's disease","volume":"95","author":"Kanof","year":"1988","journal-title":"Gastroenterology"},{"key":"10.1016\/j.crohns.2007.07.001_bib46","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1097\/00005176-199305000-00003","article-title":"Permanent growth failure in pediatric inflammatory bowel disease","volume":"16","author":"Kirschner","year":"1993","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.crohns.2007.07.001_bib47","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0950-3528(06)80020-5","article-title":"Growth and puberty in chronic inflammatory bowel disease","volume":"8","author":"Brain","year":"1994","journal-title":"Baillieres Clin Gastroenterol"},{"key":"10.1016\/j.crohns.2007.07.001_bib48","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1136\/bmj.309.6951.355","article-title":"Ulcerative colitis and Crohn's disease","volume":"309","author":"Ferguson","year":"1994","journal-title":"Br Med J"},{"key":"10.1016\/j.crohns.2007.07.001_bib49","first-page":"3","article-title":"Insulin-like growth factors and their binding proteins: biological actions","volume":"16","author":"Jones","year":"1995","journal-title":"Endocr Rev"},{"key":"10.1016\/j.crohns.2007.07.001_bib50","doi-asserted-by":"crossref","first-page":"5488","DOI":"10.1210\/en.140.12.5488","article-title":"Overexpression of insulin-like growth factor-binding protein-2 in transgenic mice reduces postnatal body weight gain","volume":"140","author":"Hoeflich","year":"1999","journal-title":"Endocrinology"},{"key":"10.1016\/j.crohns.2007.07.001_bib51","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1210\/en.138.3.1078","article-title":"Inhibition by interleukin-1 beta and tumour necrosis factor-alpha of the insulin-like growth factor I messenger ribonucleic acid response to growth hormone in rat hepatocyte primary culture","volume":"138","author":"Thissen","year":"1997","journal-title":"Endocrinology"},{"key":"10.1016\/j.crohns.2007.07.001_bib52","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1159\/000075699","article-title":"Relationships between serum IGF-1, IGFBP-2, interleukin-1beta and interleukin-6 in inflammatory bowel disease","volume":"61","author":"Street","year":"2004","journal-title":"Horm Res"},{"key":"10.1016\/j.crohns.2007.07.001_bib53","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1055\/s-2006-924972","article-title":"Gastrointestinal inflammation and the circulating IGF system in humans","volume":"38","author":"Baricevic","year":"2006","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.crohns.2007.07.001_bib54","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1097\/00005176-200302000-00014","article-title":"The insulin-like growth factor axis in children with inflammatory bowel disease","volume":"36","author":"Corkins","year":"2003","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.crohns.2007.07.001_bib55","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1210\/jcem-73-4-907","article-title":"Insulin-like growth factor-I as a reflection of body composition, nutrition, and puberty in sixth and seventh grade girls","volume":"73","author":"Wilson","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.crohns.2007.07.001_bib56","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1111\/j.1365-2036.2005.02449.x","article-title":"Infliximab reverses growth hormone resistance associated with inflammatory bowel disease","volume":"21","author":"Vespasiani-Gentilucci","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.crohns.2007.07.001_bib57","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.dld.2003.12.014","article-title":"Infliximab heals intestinal inflammatory lesions and restores growth in children with Crohn's disease","volume":"36","author":"Borrelli","year":"2004","journal-title":"Dig Liver Dis"},{"issue":"Suppl 1","key":"10.1016\/j.crohns.2007.07.001_bib58","doi-asserted-by":"crossref","first-page":"i36","DOI":"10.1136\/gut.2005.081950c","article-title":"European Crohn's and Colitis Organisation: European evidence-based consensus on the diagnosis and management of Crohn's disease: special situations","volume":"55","author":"Caprilli","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.crohns.2007.07.001_bib59","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/ibd.20069","article-title":"Linear growth improves during infliximab therapy in children with chronically active severe Crohn's disease","volume":"13","author":"Walters","year":"2007","journal-title":"Inflamm Bowel Dis"}],"container-title":["Journal of Crohn's and Colitis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1873994607000086?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1873994607000086?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/ecco-jcc\/article-pdf\/1\/1\/2\/7799148\/1-1-2.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,17]],"date-time":"2024-02-17T19:44:11Z","timestamp":1708199051000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ecco-jcc\/article-lookup\/doi\/10.1016\/j.crohns.2007.07.001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9]]},"references-count":59,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,9]]}},"alternative-id":["S1873994607000086"],"URL":"https:\/\/doi.org\/10.1016\/j.crohns.2007.07.001","relation":{},"ISSN":["1873-9946"],"issn-type":[{"value":"1873-9946","type":"print"}],"subject":[],"published":{"date-parts":[[2007,9]]}}}